Susquehanna International »

Celldex Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 275k 41.97
2023-09-30 $10M 371k 27.52
2023-06-30 $5.5M 163k 33.93
2023-03-31 $14M 394k 35.98
2022-12-31 $15M 328k 44.57
2022-09-30 $11M 391k 28.11
2022-06-30 $17M 630k 26.92
2022-03-31 $16M 469k 34.06
2021-12-31 $25M 658k 38.64
2021-09-30 $38M 707k 53.99
2021-06-30 $19M 556k 33.44
2021-03-31 $20M 981k 20.60
2020-12-31 $8.5M 486k 17.52
2020-09-30 $4.5M 307k 14.83
2020-06-30 $6.1M 471k 12.98
2020-03-31 $97k 59k 1.66
2019-12-31 $162k 72k 2.24
2019-09-30 $173k 81k 2.13
2019-06-30 $149k 56k 2.67
2019-03-31 $251k 51k 4.90